Updated clinical practice guidelines on HF drug therapy highlight the importance of targeting the sympathetic nervous system, the renin-angiotensin-aldosterone system, the natriuretic peptide system, and the sodium–glucose cotransporter-2 (SGLT2) pathway [1,2]. Here, REN is linked to hydrops fetalis.